Tag
Another nine drug companies have hopped on board with President Trump's "Most Favored Nation" drug pricing program, bringing the total number of companies participating to 14 of the…
Lawyers representing OxyContin maker Purdue Pharma, branches of the Sackler family that own it, cities, states, counties, Native American tribes, people with addiction and others across…
The need for personalization extends to sales and marketing operations too as pharma companies are increasingly needing to compete for the attention of health-care professionals (HCPs).…
Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts following President Donald Trump’s calls to bring down drug prices and…
Catalist-listed Hyphens Pharma wants to ride on the growing medical aesthetics market across South-east Asia, with the aim of becoming the region’s leading consumer healthcare group. The…
US President Donald Trump has sent letters to 17 major pharmaceutical companies demanding they cut prescription drug prices in the United States. The letters, released Thursday by the…
President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White…
The European Union’s trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%,…
President Trump said Tuesday he would issue a 50% tariff on copper brought into the U.S. and signaled he was queuing up high levies on pharmaceutical imports after a grace period that…
Torrent Pharmaceuticals agreed to take a controlling stake in JB Chemicals & Pharmaceuticals from private equity firm KKR, the latest sign of a dealmaking boom in India. Torrent will buy a…
Insulin, heart treatments and antibiotics have flowed freely across many borders for decades, exempt from tariffs in a bid to make medicine affordable. But that could soon change. For…
A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, boosting US prices by as much as 12.9 per cent if passed on, a report…
WUXI AppTec and WuXi Biologics are planning to sell some of their operations after the Chinese biotech companies were targeted by the US on national security grounds, the Financial Times…
